Instituto Universitario de Tecnologías Biomédicas
Instituto de investigación
Hospital Universitario de Getafe
Getafe, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Getafe (9)
2024
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: The VELREAL multicentre study
Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 681-687
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2017
-
Biomarkers for the acute respiratory distress syndrome: How to make the diagnosis more precise
Annals of Translational Medicine, Vol. 5, Núm. 14
2015
-
Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España
Gastroenterologia y Hepatologia, Vol. 38, Núm. 4, pp. 263-273
1999
-
Human papillomavirus-associated penile squamous cell carcinoma in HIV- positive patients
American Journal of Surgical Pathology, Vol. 23, Núm. 9, pp. 1119-1123